Moody Aldrich Partners LLC Verona Pharma PLC Transaction History
Moody Aldrich Partners LLC
- $473 Million
- Q2 2024
A detailed history of Moody Aldrich Partners LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 295,945 shares of VRNA stock, worth $8.51 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
295,945
Previous 314,912
6.02%
Holding current value
$8.51 Million
Previous $5.07 Million
15.53%
% of portfolio
0.9%
Previous 0.94%
Shares
8 transactions
Others Institutions Holding VRNA
# of Institutions
137Shares Held
66.7MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$220 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$161 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$115 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$102 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$95.3 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $1.75B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...